These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 16933377)

  • 1. Editorial comment: predictors of response--updating the traditional list.
    Gallant JE
    AIDS Read; 2006 Aug; 16(8):432-3. PubMed ID: 16933377
    [No Abstract]   [Full Text] [Related]  

  • 2. Predictors of response to highly active antiretroviral therapy.
    Low A; Markowitz M
    AIDS Read; 2006 Aug; 16(8):425-8, 430-1, 434, 436. PubMed ID: 16933376
    [TBL] [Abstract][Full Text] [Related]  

  • 3. "Absolute" or "added" predictive value?
    Koole O; Van den Ende J
    Trop Med Int Health; 2010 Mar; 15(3):382; author reply 382-4. PubMed ID: 20074084
    [No Abstract]   [Full Text] [Related]  

  • 4. Virological characterization of an infection with a dual-tropic, multidrug-resistant HIV-1 and further evolution on antiretroviral therapy.
    Masquelier B; Capdepont S; Neau D; Peuchant O; Taupin JL; Coakley E; Lie Y; Carpentier W; Dabis F; Fleury HJ;
    AIDS; 2007 Jan; 21(1):103-6. PubMed ID: 17148975
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interruption of combination antiretroviral therapy and risk of clinical disease progression to AIDS or death.
    Holkmann Olsen C; Mocroft A; Kirk O; Vella S; Blaxhult A; Clumeck N; Fisher M; Katlama C; Phillips AN; Lundgren JD;
    HIV Med; 2007 Mar; 8(2):96-104. PubMed ID: 17352766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of HIV tropism on decreases in CD4 cell count, clinical progression, and subsequent response to a first antiretroviral therapy regimen.
    Waters L; Mandalia S; Randell P; Wildfire A; Gazzard B; Moyle G
    Clin Infect Dis; 2008 May; 46(10):1617-23. PubMed ID: 18419499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HIV rules.
    Lynn T
    Br Dent J; 2009 May; 206(10):508-9. PubMed ID: 19461600
    [No Abstract]   [Full Text] [Related]  

  • 8. Delayed diagnosis of HIV infection and late initiation of antiretroviral therapy in the Swiss HIV Cohort Study.
    Wolbers M; Bucher HC; Furrer H; Rickenbach M; Cavassini M; Weber R; Schmid P; Bernasconi E; Hirschel B; Battegay M;
    HIV Med; 2008 Jul; 9(6):397-405. PubMed ID: 18410354
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The cost effectiveness of antiretroviral treatment strategies in resource-limited settings.
    Bishai D; Colchero A; Durack DT
    AIDS; 2007 Jun; 21(10):1333-40. PubMed ID: 17545710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-effectiveness of strategies for monitoring the response to antiretroviral therapy in resource-limited settings.
    Phillips AN; Gilks C; Lundgren JD
    Arch Intern Med; 2009 May; 169(9):904; author reply 904-5. PubMed ID: 19433706
    [No Abstract]   [Full Text] [Related]  

  • 11. Study on CD4 cell responses in HIV infected subjects in Nepal.
    Tiwari BR; Ghimire P; Malla S
    Nepal Med Coll J; 2008 Mar; 10(1):45-7. PubMed ID: 18700632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Epidemiology of primary drug resistance in chronically HIV-infected patients in Nordrhein-Westfalen, Germany, 2001-2005].
    Oette M; Kaiser R; Däumer M; Fätkenheuer G; Rockstroh JK; Knechten H; Mitrenga D; Beerenwinkel N; Sagir A; Pfister H; Häussinger D
    Dtsch Med Wochenschr; 2007 May; 132(18):977-82. PubMed ID: 17457780
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL-2 therapy provides no clinical benefit to HIV-infected patients on ART.
    Clin Infect Dis; 2009 Apr; 48(8):iii. PubMed ID: 19301459
    [No Abstract]   [Full Text] [Related]  

  • 14. [Antiretroviral therapy of HIV infection. German-Austrian guidelines (position in September 2008)].
    ;
    Dtsch Med Wochenschr; 2009 Jan; 134 Suppl 1():S4-15. PubMed ID: 19172554
    [No Abstract]   [Full Text] [Related]  

  • 15. WHO HIV clinical staging or CD4 cell counts for antiretroviral therapy eligibility assessment? An evaluation in rural Rakai district, Uganda.
    Kagaayi J; Makumbi F; Nakigozi G; Wawer MJ; Gray RH; Serwadda D; Reynolds SJ
    AIDS; 2007 May; 21(9):1208-10. PubMed ID: 17502733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV surveillance, public health, and clinical medicine--will the walls come tumbling down?
    Fairchild AL; Bayer R
    N Engl J Med; 2011 Aug; 365(8):685-7. PubMed ID: 21864165
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of HIV viral load, CD4 cell count and antiretroviral therapy on human papillomavirus prevalence in urine samples of HIV-infected men.
    Jong E; van Gorp EC; Mulder JW; Tol A; Smits PH
    Int J STD AIDS; 2009 Apr; 20(4):262-4. PubMed ID: 19304972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simple methods on supporting ARV therapy services.
    Djauzi S
    Acta Med Indones; 2008 Apr; 40(2):53-4. PubMed ID: 19054880
    [No Abstract]   [Full Text] [Related]  

  • 19. Predictive factors for immunological and virological endpoints in Thai patients receiving combination antiretroviral treatment.
    Srasuebkul P; Ungsedhapand C; Ruxrungtham K; Boyd MA; Phanuphak P; Cooper DA; Law MG
    HIV Med; 2007 Jan; 8(1):46-54. PubMed ID: 17305932
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Causes for low positive predictive values of CD4 counts for antiretroviral treatment failure.
    Eisenhut M
    Int J Infect Dis; 2008 Sep; 12(5):565; author reply 566. PubMed ID: 18403226
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.